Cargando…
Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection
BACKGROUND: Epidemiologic data suggest that patients with systemic lupus erythematosus (SLE) have a lower risk of breast cancer than women in the general population. In light of mechanistic studies suggesting that anti-DNA antibodies have anti-cancer effects, we sought to examine breast cancer risk...
Autores principales: | Shah, Ami A., Igusa, Takeru, Goldman, Daniel, Li, Jessica, Casciola-Rosen, Livia, Rosen, Antony, Petri, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905617/ https://www.ncbi.nlm.nih.gov/pubmed/33632283 http://dx.doi.org/10.1186/s13075-021-02449-3 |
Ejemplares similares
-
Anti‐retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis
por: Goules, Andreas, et al.
Publicado: (2019) -
Review: Cancer‐Induced Autoimmunity in the Rheumatic Diseases
por: Shah, Ami A., et al.
Publicado: (2015) -
Autoantibody clustering of lupus-associated pulmonary hypertension
por: Mizus, Marisa, et al.
Publicado: (2019) -
Two Major Autoantibody Clusters in Systemic Lupus Erythematosus
por: Ching, Kathryn H., et al.
Publicado: (2012) -
Scleroderma Autoantigens Are Uniquely Fragmented by Metal-catalyzed Oxidation Reactions: Implications for Pathogenesis
por: Casciola-Rosen, Livia, et al.
Publicado: (1997)